Literature DB >> 4136589

Chronic myelomonocytic leukemia in adults.

P A Miescher, J J Farguet.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4136589

Source DB:  PubMed          Journal:  Semin Hematol        ISSN: 0037-1963            Impact factor:   3.851


× No keyword cloud information.
  9 in total

1.  Disorders of the mononuclear phagocyte system. An analytical review.

Authors:  G Meuret
Journal:  Blut       Date:  1977-04

2.  [Successful therapy of chronic myelomonocytic leukemia with vp 16-213 (author's transl)].

Authors:  L Labedzki; H J Illiger
Journal:  Blut       Date:  1979-05

3.  Treatment of chronic myelomonocytic leukemia. Vincristine and prednisone therapy during symptomatic phase or after transformation to acute leukemia.

Authors:  R Taetle; R Haerr
Journal:  West J Med       Date:  1985-10

4.  Chronic myelomonocytic leukemia: light and electron microscopy of the bone marrow.

Authors:  J Thiele; K F Vykoupil; A Georgii
Journal:  Blut       Date:  1979-09

Review 5.  Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.

Authors:  D M Layton; G J Mufti
Journal:  Blut       Date:  1986-12

6.  Allogeneic bone marrow transplantation as primary therapy for chronic myelomonocytic leukemia.

Authors:  S J Forman; M R O'Donnell; K G Blume; D I Feinstein
Journal:  Blut       Date:  1987-03

7.  Sucessful treatment of severe bone pain and acute arthritis in chronic myelomonocytic leukaemia by cytosine arabinoside.

Authors:  D Douer; A Weinberger; M Djaldetti; J Pinkhas
Journal:  Ann Rheum Dis       Date:  1977-04       Impact factor: 19.103

8.  [Myelomonocytic leukemia: clinical, cytological, and cytogenetic studies of acute, subacute, and chronic forms (author's transl)].

Authors:  S Mende; H H Fülle; A Knuth; I Weissenfels
Journal:  Blut       Date:  1977-07-20

9.  Prognostic factors and survival in chronic myelomonocytic leukaemia (CMML).

Authors:  A N Stark; J Thorogood; C Head; B E Roberts; C S Scott
Journal:  Br J Cancer       Date:  1987-07       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.